Literature DB >> 4835733

Aspirin intolerance. II. A prospective study in an atopic and normal population.

G A Settipane, F H Chafee, D E Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4835733     DOI: 10.1016/0091-6749(74)90081-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  22 in total

Review 1.  Simple analgesics.

Authors:  J Parkhouse
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Aspirin-induced asthma.

Authors:  L T Vaszar; D D Stevenson
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

3.  Aspirin induced adverse skin reactions: new pathophysiological aspects.

Authors:  B Wedi; A Kapp
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 4.  The use of analgesics in patients with asthma.

Authors:  S Levy; G Volans
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 5.  Preventing and managing drug-induced anaphylaxis.

Authors:  K L Drain; G W Volcheck
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Editorial: Allergy to aspirin.

Authors: 
Journal:  Br Med J       Date:  1974-07-27

Review 7.  Adverse reactions and interactions with aspirin. Considerations in the treatment of the elderly patient.

Authors:  J Karsh
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

8.  [ASA-intolerance syndrome and persistent rhinosinusitis : Differential diagnosis and treatment].

Authors:  H Kirsche; L Klimek
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

9.  Histaminemia after aspirin challenge in aspirin-sensitive asthmatics.

Authors:  M Szmidt; I Grzelewska-Rzymowska; J Rozniecki; M L Kowalski; I Rychlicka
Journal:  Agents Actions       Date:  1981-04

10.  The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients.

Authors:  H Vally; M L Taylor; P J Thompson
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.